QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2

Hilden, Germany, and Germantown, Maryland, February 26, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. The new kit detects the novel coronavirus SARS-CoV-2 and adds rapid Sample to Insight syndromic testing to QIAGEN’s... Read more

BD Expands Single Cell Portfolio with Combined Whole Transcriptome and Protein Analysis Solution for High Dimensional Immunology Research

BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit is designed and tested to work with BD Rhapsody™ Single-Cell Analysis System, BD® AbSeq reagents and BD® Single-Cell Multiplexing KitOct 28, 2019 Franklin Lakes, N.J., October 28, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the availability of BD Rhapsody WTA Amplification kit for single-cell... Read more